Hamilton Thomas Edward
SEC insider (Form 3/4/5 filer). CIK 0001769848. Director at Larimar Therapeutics, Inc. (LRMR) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in BALA CYNWYD, PA.
Companies Hamilton Thomas Edward has filed insider reports for
- Larimar Therapeutics, Inc. (LRMR): Director
- ANNALY CAPITAL MANAGEMENT INC (NLY): Director
Hamilton Thomas Edward
CIK: 0001769848
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 6, 2026LRMR
Larimar Therapeutics, Inc.
PurchaseDirect50K shares at avg. $3.34$167K - Jun 10, 2026NLY
ANNALY CAPITAL MANAGEMENT INC
AwardDirectDeferred Stock Units
8.6K shares- - May 19, 2026LRMR
Larimar Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
55.2K shares- - Feb 27, 2026LRMR
Larimar Therapeutics, Inc.
PurchaseDirect100K shares at avg. $5.00$500K - May 14, 2025NLY
ANNALY CAPITAL MANAGEMENT INC
AwardDirectDeferred Stock Units
9K shares- - May 13, 2025LRMR
Larimar Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 |  LRMR Larimar Therapeutics, Inc. | Purchase | 50,000 | $3.34 | $166,890 | Direct |
| Jun 10, 2026 |  NLY ANNALY CAPITAL MANAGEMENT INC | Award Deferred Stock Units | 8,641 | - | - | Direct |
| May 19, 2026 | LRMR Larimar Therapeutics, Inc. | Award Stock Option (Right to Buy) | 55,150 | - | - | Direct |
| Feb 27, 2026 | LRMR Larimar Therapeutics, Inc. | Purchase | 100,000 | $5.00 | $500,000 | Direct |
| May 14, 2025 | NLY ANNALY CAPITAL MANAGEMENT INC | Award Deferred Stock Units | 8,961 | - | - | Direct |
| May 13, 2025 | LRMR Larimar Therapeutics, Inc. | Award Stock Option (Right to Buy) | 19,000 | - | - | Direct |
1-6 of 6 transactions